| Mrs Ilia M Dominguez, RN | |
|
Ave Agustin Ramos Calero Int 111 Bzn 737, Isabela, PR 00662 | |
| (787) 830-2765 | |
| (787) 830-0465 |
| Full Name | Mrs Ilia M Dominguez |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse |
| Location | Ave Agustin Ramos Calero Int 111 Bzn 737, Isabela, Puerto Rico |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1437272655 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | 12514 (Puerto Rico) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Ilia M Dominguez, RN Po Box 962, Aguada, PR 00602-0962 Ph: (787) 241-8886 | Mrs Ilia M Dominguez, RN Ave Agustin Ramos Calero Int 111 Bzn 737, Isabela, PR 00662 Ph: (787) 830-2765 |
News Archive
Similar to blood sugar, various biomarkers could in future be identified using just a few drops of blood. Researchers at Ruhr-Universität Bochum are developing a multi-analyte test strip for this purpose that will open up new potentials in personalised medicine by facilitating the continuous measurement of various parameters.
New York and federal officials report final agreement allowing the state to reinvest $8 billion in Medicaid savings to support hospital overhauls and expand primary medical care over the next five years. The goal of the Medicaid waiver is to reduce avoidable hospital use by 25 percent while helping financially struggling hospitals shift to more primary and outpatient care (4/14).
Novelos Therapeutics, Inc., a biopharmaceutical company focused on the development of therapeutics to treat cancer and hepatitis, today announced that the primary endpoint of improvement in overall survival was not met in Novelos' pivotal Phase 3 trial in advanced non-small cell lung cancer (NSCLC) studying its lead product, NOV-002, in combination with first-line chemotherapy. Detailed trial results are expected to be presented via appropriate scientific venue later this year.
In neuroendocrine tumor treatment, different methods of predicting patient response may be required for different patients, according to new research published in the October issue of The Journal of Nuclear Medicine. By tailoring the method to the specific patient, physicians may better predict the effectiveness of treatment.
› Verified 9 days ago
Mrs. Lorna M Romero, BSNRN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 136 Calle Marina, Isabela, PR 00662 Phone: 787-830-2707 Fax: 787-830-0465 | |
Mr. Hector Ivan Carides, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: Urb. Santa Rosa, C/ Inglaterra 1355, Isabela, PR 00662 Phone: 787-599-6630 | |
Mrs. Carmen L Melon Ii, LPN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: Ave Agustin Ramos Calero Int 111, Isabela, PR 00662 Phone: 787-830-2765 Fax: 787-830-0465 | |
Nilsa Mercado Iv, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: Ave Agustin Ramos Calero Int 111 Bzn 737, Isabela, PR 00662 Phone: 787-830-2765 Fax: 787-830-0465 | |
Luis O Fernandez, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: Ave Agustin Ramos Calero Int 111 Bzn 737, Isabela, PR 00662 Phone: 787-830-2765 Fax: 787-830-0465 | |
Luz M Ramos, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: Ave Agustin Ramos Calero Int 111 Bzn 737, Isabela, PR 00662 Phone: 787-830-2765 Fax: 787-830-0465 | |
Mrs. Maribel Lopez, LPN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: Ave Agustin Ramos Calero, Box 737, Isabela, PR 00662 Phone: 787-830-2725 Fax: 787-830-0465 |